{"provider_url":"https://hatena.blog","provider_name":"Hatena Blog","author_url":"https://blog.hatena.ne.jp/CTD_GIM/","author_name":"CTD_GIM","height":"190","published":"2024-12-30 09:27:44","blog_title":"\u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a","title":"\u5b9f\u81e8\u5e8a\u306b\u304a\u3051\u308bANCA\u95a2\u9023\u8840\u7ba1\u708e\u3078\u306e\u30b9\u30c6\u30ed\u30a4\u30c9\u6025\u901f\u6f38\u6e1b\uff08PEXIVAS\u8a66\u9a13\u30ec\u30b8\u30e1\u30f3\uff09\u306e\u89e3\u6790","type":"rich","url":"https://ctd-gim.hatenablog.com/entry/2024/12/30/092744","version":"1.0","categories":[],"description":"Nagle S, Nguyen Y, Guerry MJ, et al. Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis. Ann Rheum Dis. Published online November 20, 2024. doi:10.1136/ard-2024-226339 \u5b9f\u81e8\u5e8a\u3067\u306eANCA\u95a2\u9023\u8840\u7ba1\u708e\u3078\u306eRTX\uff0b\u30b9\u30c6\u30ed\u30a4\u30c9\u6025\u901f\u6f38\u6e1b\u306f\u3001Cre\u9ad8\u5024\u60a3\u8005\u306b\u306f\u5371\u967a\u304b\u3082\u3057\u308c\u306a\u3044\u3001\u3068\u3044\u3046\u5831\u2026","width":"100%","blog_url":"https://ctd-gim.hatenablog.com/","image_url":null,"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fctd-gim.hatenablog.com%2Fentry%2F2024%2F12%2F30%2F092744\" title=\"\u5b9f\u81e8\u5e8a\u306b\u304a\u3051\u308bANCA\u95a2\u9023\u8840\u7ba1\u708e\u3078\u306e\u30b9\u30c6\u30ed\u30a4\u30c9\u6025\u901f\u6f38\u6e1b\uff08PEXIVAS\u8a66\u9a13\u30ec\u30b8\u30e1\u30f3\uff09\u306e\u89e3\u6790 - \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>"}